Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News

Newer Groundwater Linked to Increased PD Risk

Drinking water sourced from newer groundwater or carbonate aquifers is linked to a significantly increased risk for Parkinson’s disease, a new study shows.

AAN Issues Guidance on Consumer Wearables in Neurologic Care

New AAN guidance examines how consumer wearable devices can support neurologic care, including epilepsy monitoring and sleep tracking — while cautioning that many of them are insufficiently validated.

When Hearing Fails, Vision Rehab Falls Short

Patients with hearing impairment who receive vision rehabilitation are 42% less likely than those with normal hearing to achieve a meaningful functional improvement, a recent study shows.

AHS Recommends Annual Migraine Screening for Girls and Women

A new recommendation from the American Headache Society calls for annual migraine screening as part of preventive care for girls and women — from adolescence through menopause.

Biologics Don’t Promote Respiratory Infections

Reassuring data support the safety of biologics as an option for asthma care.

Biologics, Phototherapy in Psoriasis: Cost-Benefit Compared

A simulated analysis in psoriasis highlights divergent patient and payer incentives and inconsistent coverage strategies behind barriers to phototherapy uptake.

Todays Updates

Older Adults With Advanced Cancer Prioritize Quality of Life

Most older adults with advanced cancer value quality of life over extending survival, but that preference may not translate to clinical care or outcomes.

Todays Updates

Older Adults With Advanced Cancer Prioritize Quality of Life

Most older adults with advanced cancer value quality of life over extending survival, but that preference may not translate to clinical care or outcomes.

Latest News

Drinking water sourced from newer groundwater or carbonate aquifers is linked to a significantly increased risk for Parkinson’s disease, a new study shows.

New AAN guidance examines how consumer wearable devices can support neurologic care, including epilepsy monitoring and sleep tracking — while cautioning that many of them are insufficiently validated.

Patients with hearing impairment who receive vision rehabilitation are 42% less likely than those with normal hearing to achieve a meaningful functional improvement, a recent study shows.

A new recommendation from the American Headache Society calls for annual migraine screening as part of preventive care for girls and women — from adolescence through menopause.

Reassuring data support the safety of biologics as an option for asthma care.

A simulated analysis in psoriasis highlights divergent patient and payer incentives and inconsistent coverage strategies behind barriers to phototherapy uptake.

News All Time

Hospitalists Get Creative to Find Time for Research

Sometimes that may mean carving out an hour here or there during the day and, sometimes, it may mean working on a day off.

Rethinking Osteoarthritis: Inflammation, Metabolism, Repair

Emerging regenerative and cell-based therapies promise cartilage repair, yet most are preclinical or limited by durability and safety — underscoring the need for rigorous stratification.

Jamaica to End Medical Cooperation Program With Cuba

Jamaica will end a medical cooperation program with Cuba, ⁠as the two governments were unable to agree on the terms ⁠for a new arrangement.

Saline Lavage Shows No Clinical Benefit in Pleural Infection

Saline lavage, alone or combined with intrapleural enzyme therapy, confers no clinically meaningful advantage over intrapleural enzyme therapy alone in patients with pleural infection.

Your Patient Doesn’t Like Your Accent or Color: Now What?

Many doctors facing racism from patients stay silent, doubting they’ll be heard. Experts share strategies for handling bias when institutions fall short.

Does Cannabis Really Help PTSD? New Data Cast Doubt

Quitting cannabis may yield greater improvements in PTSD symptoms than continued use in adults with both PTSD and cannabis use disorder, a small study suggests.

Women At Risk as Taliban Curbs Hit Afghan Healthcare

Restrictions imposed by the Taliban are jeopardising the lives of women and their children who are sometimes denied emergency treatment, a ⁠U.N. human rights expert said.

Sterile Wolbachia-Infected Mosquitoes Reduce Dengue Risk

Releasing sterile Wolbachia-infected male Aedes aegypti mosquitoes substantially reduces the risk for dengue.

Australia’s Medicare Reforms Face Rural Stress Test

A parliamentary committee has launched an inquiry into the rural impacts of changes aimed at strengthening Medicare access and funding. Experts offer mixed reviews.

‘You Aren’t Trapped’: Hundreds of US Nurses Choosing Canada

The relocations are part of a new surge of American nurses, doctors, and other healthcare workers moving to Canada, and specifically British Columbia.

March 4: A Match Deadline Med Students Can’t Miss

The deadline is 9 PM ET Wednesday for fourth-year students to submit their residency preference lists.

Exclusive-South Carolina Seeks Non-CDC Reinforcements to Contain Growing Measles Outbreak

A dozen public health experts are arriving in South Carolina to help the state contain the largest U.S. measles outbreak in more than 30 years, but they're not coming from...

BMI Shapes Oxytocin Needs in Labor Induction

Individuals receiving maximum oxytocin doses have elevated risk for cesarean delivery and postpartum hemorrhage, but the risks are attenuated in those with elevated BMI.

Match Making Made Easy: ‘Take a Deep Breath’

Med students have until March 4 to finalize their Match lists. There is a lot to consider before then.

How These Doctors Fight the Social Media Trust War

As trust in healthcare erodes and disinformation thrives on social media, a small but determined group of physicians wants to win.

FDA Approves New Narcan Packaging, Aiming to Boost Carry Rates

FDA Approves New Narcan Packaging, Aiming to Boost Carry Rates

Recommended News For You

How the metastasis of cancer is driven by cellular plasticity.

Maintenance Rituximab Improves Survival in Elderly MRD-Negative MCL Patients.

A higher risk of chemotherapy-induced peripheral neuropathy is associated with a deficiency in vitamin D prior to treatment.

Even when they are not paying attention, children are still learning.

COVID-19 mRNA vaccines could unlock the next revolution in cancer treatment

As compared to proton therapy, proton therapy is very effective in treating esophageal cancer.

FDA Investigating Blood Cancer Risk With Gene Therapy Skysona

Recommended Articles For You

Understanding Macrocytosis: Causes, Symptoms, and Treatment Options  

What Is Gastrinoma? Understanding This Rare Tumor and Its Treatment Options 

Ear Emergency: Understanding the Causes and Treatment for Auricular Hematoma 

Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Charles III, King of Kings, is Cancerous.

2.

In early dementia, SSRIs enhance cognition and major depression.

3.

Outcomes in Resected Melanoma Influenced by Timing of Recurrence

4.

There is a 40% reduction in the risk of 9 cancers with good cardiorespiratory fitness.

5.

Worse Outcomes After Esophagectomy at Private Equity-Owned Hospitals

1.

AI Revolutionizes Immunotherapy: Unveiling Biomarkers with Machine Intelligence

2.

Predicting Incidental Prostate Cancer in BPH Surgery Patients

3.

Understanding Axitinib: What You Need To Know For Your Treatment Plan

4.

Tremelimumab: A Potential Breakthrough in Cancer Treatment

5.

Innovative Marketing Strategies for Oncology Drugs: A Clinician’s Take on Digital and B2B Trends

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.

2.

Navigating the Complexities of Ph Negative ALL - Part III

3.

Navigating the Complexities of Ph Negative ALL - Part IV

4.

Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment

5.

Navigating the Complexities of Ph Negative ALL - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot